Intra-articular injections of ketamine and 25% dextrose improve clinical and pathological outcomes in the monosodium iodoacetate model of osteoarthritis.
Yashashri C ShettyAmol E PatilSharmila V JalgaonkarNirmala N RegeSweta SalgaonkarPrachi A TeltumbdeSarang KshirsagarParesh G KoliSmita BrahmaPublished in: Journal of basic and clinical physiology and pharmacology (2018)
The NMDA antagonist effect of ketamine and the proliferative effect of 25% dextrose showed a reduction in pain and disease activity in the OA model.